Agenus Inc. Announces Special Meeting for Stockholder Vote on Reverse Stock Split

TL;DR

<b>Agenus Inc. will hold a special meeting on April 3, 2024, to vote on a proposed 1-for-20 reverse stock split.</b>

AI Summary

AGENUS INC (AGEN) filed a Proxy Statement (DEF 14A) with the SEC on February 26, 2024. Agenus Inc. is holding a Special Meeting of Stockholders on April 3, 2024, at 10:00 A.M. ET. The primary proposal is to approve an amendment to the Certificate of Incorporation to effect a 1-for-20 reverse stock split. Stockholders of record as of February 9, 2024, are entitled to vote. The meeting will be conducted via a live audio web conference at www.virtualshareholdermeeting.com/AGEN2024SM. The company is soliciting proxies for this meeting.

Why It Matters

For investors and stakeholders tracking AGENUS INC, this filing contains several important signals. The reverse stock split is intended to increase the per-share market price of the company's common stock, potentially making it more attractive to investors and meeting stock exchange listing requirements. Shareholders need to be aware of the implications of a reverse stock split, which can affect the number of shares they own and potentially the stock's liquidity.

Risk Assessment

Risk Level: — AGENUS INC shows moderate risk based on this filing. The company is proposing a reverse stock split, which is often a sign of financial distress or a strategy to avoid delisting, indicating potential underlying issues with the stock's performance.

Analyst Insight

Stockholders should carefully consider the implications of the proposed 1-for-20 reverse stock split on their investment and the company's future.

Key Numbers

• 1-for-20 — Reverse Stock Split Ratio (Proposal 1)
• April 3, 2024 — Special Meeting Date (Notice of Special Meeting)
• 10:00 A.M., Eastern Time — Special Meeting Time (Notice of Special Meeting)
• February 9, 2024 — Record Date (Entitled to vote)

Key Players & Entities

• Agenus Inc. (company) — Registrant
• Garo H. Armen (person) — Chief Executive Officer
• February 9, 2024 (date) — Record Date
• April 3, 2024 (date) — Date of Special Meeting
• 1-for-20 (dollar_amount) — Reverse stock split ratio

FAQ

Risk Factors

• Reverse Stock Split [medium — financial]: The company is seeking approval for a 1-for-20 reverse stock split to increase the per-share market price of its common stock.

Industry Context

Agenus Inc. operates in the biotechnology sector, focusing on cancer immunotherapies. Companies in this sector often face significant capital needs and market volatility.

Regulatory Implications

The filing is a DEF 14A, a Definitive Proxy Statement, filed under the Securities Exchange Act of 1934, which requires public companies to provide shareholders with information before a shareholder meeting.

What Investors Should Do

1. Review the proxy statement carefully to understand the rationale and implications of the proposed reverse stock split.
2. Vote your shares by proxy or attend the virtual meeting to cast your vote on Proposal 1.
3. Monitor the company's stock performance and any subsequent announcements following the special meeting.

Key Dates

• 2024-04-03: Special Meeting of Stockholders — Vote on reverse stock split
• 2024-02-09: Record Date — Determines eligibility to vote
• 2024-02-26: Filing Date — Filing of Definitive Proxy Statement

Glossary

Reverse Stock Split

A corporate action in which a company reduces the number of its outstanding shares by consolidating them. (Aims to increase the per-share price and potentially meet exchange listing requirements.)

Year-Over-Year Comparison

This filing is a proxy statement for a special meeting, distinct from regular quarterly or annual reports. It focuses on a specific corporate action rather than a broad financial update.

Key Financial Figures

• $12,000 — r the Special Meeting for a base fee of $12,000 plus fees for additional services, if n
• $94.86 — res have an initial conversion price of $94.86 and are currently convertible into 333,

Filing Documents

• d755846ddef14a.htm (DEF 14A) — 132KB
• g755846dsp022.jpg (GRAPHIC) — 118KB
• g755846dsp023.jpg (GRAPHIC) — 119KB
• 0001193125-24-046230.txt (&nbsp;) — 449KB

From the Filing

DEF 14A 1 d755846ddef14a.htm DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Agenus Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Table of Contents AGENUS INC. NOTICE OF SPECIAL MEETING OF STOCKHOLDERS Date Time Webcast Address April 3, 2024 10:00 A.M., Eastern Time Live audio web conference at www.virtualshareholdermeeting.com/AGEN2024SM Proposals 1. To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued and outstanding common stock at a ratio of 1-for-20. 2. To consider any other business as may properly come before Special Meeting or any postponement or adjournment of the meeting. Record Date You are entitled to vote if you were a stockholder of record on February 9, 2024. A list of stockholders entitled to vote will be open for examination by any stockholder for any purpose germane to the Special Meeting for ten days before the meeting during ordinary business hours at our principal offices at 3 Forbes Road, Lexington, Massachusetts 02421. It is important that your shares be represented at the Special Meeting. Therefore, whether or not you plan to attend the meeting virtually, please complete your proxy and return it to us. If you attend the Special Meeting virtually and wish to vote at the meeting, your proxy will not be used. You may also vote your shares over the internet or by telephone. Instructions for internet or telephonic voting are printed on your proxy card. By order of the Board of Directors, Garo H. Armen, Chief Executive Officer February 26, 2024 Table of Contents TABLE OF CONTENTS Page GENERAL INFORMATION ABOUT OUR VIRTUAL STOCKHOLDER MEETING 3 8 PROPOSAL 1 10 ADDITIONAL INFORMATION 14 OTHER BUSINESS 15 APPENDIX A PROPOSED CERTIFICATE OF AMENDMENT A-1 Table of Contents AGENUS INC. 3 Forbes Road Lexington, Massachusetts 02421 Telephone: (781) 674-4400 PROXY STATEMENT For the Special Meeting of Stockholders To be Held on April 3, 2024 General The enclosed proxy is solicited by the Board of Directors (the Board) of Agenus Inc. (the Company, Agenus, we or us), for use at the Special Meeting of the Companys stockholders (the Special Meeting) to be held on April 3, 2024, at 10:00 A.M. Eastern Time and at any adjournments thereof. Whether or not you expect to attend the meeting, please vote your shares as promptly as possible to ensure that your vote is counted. The proxy materials will be furnished to stockholders on or about February 29, 2024. Revocability of Proxy and Solicitation Any stockholder executing a proxy that is solicited hereby has the power to revoke it prior to the Special Meeting. Revocation may be made by voting over the internet (with only your latest internet vote counted), voting by telephone (with only your latest telephonic vote counted), attending the Special Meeting and voting the shares of stock, or by delivering a later-dated, properly executed proxy in accordance with the instructions below. We have engaged Morrow Sodali LLC (Morrow Sodali) as the proxy solicitor for the Special Meeting. Some of our directors, officers and employees may also solicit proxies by telephone, e-mail, and in person. Record Date Stockholders of record at the close of business on February 9, 2024 (the Record Date) will be entitled to receive notice of, attend and vote at the meeting. Action to be Taken Under Proxy Unless otherwise directed by the giver of the proxy, the persons named in the form of proxy, namely, Garo Armen, our Chief Executive Officer, Robin Abrams, our Chief Legal Officer, and Christine Klaskin, our Vice President, Finance and Principal Financial and Accounting Officer, or any one of them who acts, will vote: FOR approval of an amendment to the Companys Amended and Restated Certificate of Incorporation, as amended (the Certificate of Incorporation), to effect a reverse stock split of our issued and outstanding common stock at a ratio of 1-for-20 (Proposal No. 1the Proposal to Effect a Reverse Stock Split). Vote Required; Quorum; Broker Non-votes As of the Record Date, there were 399,246,272 shares of com

View Full Filing

View this DEF 14A filing on SEC EDGAR